What the research shows: early pilot study
One small study of a brief telehealth version of PRT, with no comparison group. The results are encouraging, but PRT has not yet been tested for fibromyalgia in a randomized trial.
Fibromyalgia and the nervous system
In fibromyalgia, pain is thought to come mainly from increased pain and sensory processing in the central nervous system, rather than from damage in the muscles or joints. That is why it often comes with other symptoms such as fatigue, sleep and memory problems, and sensitivity to light, sound or touch. (Fitzcharles et al., 2021)
What the research shows
A 2025 pilot study tested a three-session telehealth version of PRT in 35 adults with fibromyalgia. 33 completed all sessions. On average, pain intensity, the impact of pain on daily life, and fear of pain all went down over the following three months. At three months, 42% of people who completed treatment rated themselves “much improved” or “very much improved”. (Sturgeon et al., 2025)
What this does and doesn’t tell us: there was no comparison group, so we can’t tell how much of the improvement came from PRT itself. The authors call for larger randomized trials. For now, PRT for fibromyalgia is promising but unproven.
How PRT approaches fibromyalgia
PRT doesn’t replace your medical care for fibromyalgia. It adds a focus on the nervous system’s sense of threat:
- Understanding why pain can be widespread and changeable without damage in the tissues
- Somatic tracking to reduce fear of flare-ups
- Gradually reclaiming activities, at a pace that feels safe
- Working on stress, sleep and habits that keep the alarm switched on
Your first session looks at your history in detail to judge whether PRT is a good fit for you.